Nov
29
2016
When measuring HbA1c, many clinical laboratories do not report the presence of hemoglobin variants, whereas others report them only if they interfere with HbA1c measurement. As routine HbA1c testing may incidentally yield information regarding hemoglobin variants that can affect...
Sep
25
2016
The annual meeting of the D2d research team is held in Arlington, VA. On Sunday evening, principal investigator Dr. Pittas presents the State of D2d, which remains strong and is getting stronger. The meeting focuses on participant retention since...
Jun
27
2016
A participant from the Pennington Biomedical Research Center site is the 2,000th participant enrolled in D2d. The participant completed the study.
Nov
20
2015
A participant from the Northwestern University site is the 1,500th participant enrolled in D2d. The participant completed the study.
Nov
08
2015
The annual meeting of the D2d research team is held in Arlington, VA. On Sunday evening, principal investigator Dr. Pittas presents the State of D2d, which remains strong. The meeting reinforces the importance of participant recruitment and emphasizes the...
Apr
20
2015
A participant from the MedStar Community Clinical Research Center D2d site is the 1,000th participant enrolled in D2d. The participant completed the study.
Nov
20
2014
The D2d Data and Safety Monitoring Board (DSMB) meets twice a year to review the study’s progress. At this meeting, the DSMB is impressed with the improvement in recruitment and is pleased with enrollment metrics. The secret to the...
Nov
17
2014
The annual meeting of the D2d research team is held in Crystal City, MD. On Sunday evening, principal investigator Dr. Pittas presents the State of D2d. The meeting focuses on participant recruitment and retention. Site staff share their experience...
Sep
15
2014
The D2d team publishes its first manuscript related to D2d: The rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial.
The manuscript is published in Diabetes Care.
Aug
28
2014
A participant at the Atlanta VA Medical Center site is the 500th participant enrolled in D2d. The participant completed the study.